Top DaVita Nephrologists Sharing Expertise Through Social Media
August 01 2011 - 10:43AM
Business Wire
DaVita Inc. (NYSE: DVA), a leading provider of kidney care
services for those diagnosed with end stage renal disease (ESRD)
and chronic kidney disease (CKD), today announced that three of the
company’s top nephrologists are sharing their nephrology expertise,
perspectives and resources through social media.
DaVita’s newest bloggers are members of DaVita’s Office of the
Chief Medical Officer: Allen R. Nissenson, M.D., Mahesh Krishnan,
M.D., and Robert Provenzano, M.D.
“We’ve found that we’re able to engage with physicians and the
entire kidney care community in a whole new way,” said Dr. Allen
Nissenson, chief medical officer at DaVita®. “With social media, we
have the opportunity to host key conversations online from public
policy to the quality of patient care. There just aren’t many
resources like this for nephrologists or students studying
nephrology.”
Dr. Allen Nissenson hosts a blog on DaVita’s new
physician-focused site where he shares his perspectives and
expertise on nephrology-specific issues on a bi-weekly basis. Dr.
Nissenson also invites industry-leading experts to share thoughts
and comments on his blog.
Dr. Mahesh Krishnan, vice president of research for DaVita
Clinical Research,® shares a monthly list of his top clinical reads
featuring thought-provoking articles from clinical journals and
publications, and well-respected nephrology blogs.
Dr. Robert Provenzano, widely known to be an industry specialist
on Accountable Care Organizations (ACOs), writes about the impact
of ACOs on the renal industry on DaVita’s Accountable Kidney Care
Collaborative site. Dr. Provenzano also manages his own Twitter
account where he tweets primarily about issues related to ACOs and
nephrology.
Follow DaVita’s top physicians by clicking the following
links:
Allen R. Nissenson, M.D., FACPChief Medical
OfficerAllen’s BlogDaVita.com/AllenMahesh Krishnan,
M.D.Mahesh’s Top ReadsDaVita.com/MaheshRobert Provenzano,
M.D., FACPDr. Provenzano on
TwitterTwitter.com/DrBobProhttp://accountablekidneycare.org/akccblog/DaVita
and DaVita Clinical Research are registered trademarks of DaVita
Inc. All other trademarks are the property of their respective
owners.
About DaVita
DaVita Inc., a Fortune 500® company, is a leading provider of
kidney care in the United States, delivering dialysis services and
education to patients with chronic kidney failure and end stage
renal disease. As of March 31, 2011, DaVita operated or provided
administrative services at 1,642 dialysis facilities, serving
approximately 128,000 patients. DaVita develops, participates in
and donates to numerous programs dedicated to transforming
communities and creating positive, sustainable change for children,
families and our environment. The company’s leadership development
initiatives and corporate social responsibility efforts have been
recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu,
among others. For more information, please visit
www.davita.com.
DaVita (NYSE:DVA)
Historical Stock Chart
From May 2024 to Jun 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Jun 2023 to Jun 2024